Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

All News and Research Articles

The Drug Enforcement Administration (DEA) has officially changed tramadol from a non-classified drug to a schedule IV drug, effective August 18, 2014.1 First approved by the US Food and Drug Administration (FDA)  in 1995, tramadol (Ultram) is a centrally acting opioid analgesic.
Tau protein levels and other types of biomarkers may help doctors better diagnose concussions and even monitor symptoms, according to new research. A recent study looked at professional hockey players in Sweden, monitoring their tau protein levels after physical exertion and concussion injuries.
It has long been known that music can be used to calm and relax people. A new study also shows that music therapy can be used to reduce postoperative pain.
People with chronic low back pain appear to lose their enjoyment of eating, resulting in a blunting of feelings of satisfaction, satiety, and pleasure. This can lead to a cycle of over-eating and weight gain, which than contribute to continued low back pain. Innovative new research is now examining how pain influences eating behaviors that led to obesity.
Do unconscious patients experience pain? And if so, how does one measure pain in a non-responsive patient? According to Canadian researchers, respiratory rates (RR) of traumatic brain injury (TBI) patients may be one vital sign used to monitor pain levels in conscious and unconscious patients in the intensive care unit.
Spinal cord simulation (SCS) is proving itself a safe and effective method of treating some chronic back pain patients who have failed at least 6 months of conventional treatment, according to the results of a newly published study in the journal Pain Medicine.1
Medical marijuana, although effective for some types of pain, does not appear to relieve chronic pain in patients with rheumatoid arthritis.
It has been known that people with rheumatoid arthritis are twice as likely to develop heart problems than the general population. But pinpointing patients who need stepped-up heart disease prevention efforts has been a challenge for physicians who treat rhuematoid arthritis.